m+Medelevator.RU
← Поиск публикаций
American journal of preventive cardiology · 2026

Age and sex specific coronary plaque characteristics among South Asians: Insights from the DILWALE CTA study.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Satish Priyanka, Vajramani Aashna, Gupta Swapnil, Ma Tsung-Wei, Prasad Tanushree, Lakshmanan Suvasini, Budoff Matthew, Kalra Dinesh K, Khan Muhammad Shahzeb, Leipsic Jonathon, Alsaid Amro, Kulkarni Anandita

Аннотация

BACKGROUND: South Asians (SA) face disproportionately high rates of premature coronary artery disease (CAD), often underestimated by traditional risk calculators. We aim to characterize CT angiography (CTA)-derived plaque composition, plaque burden, and association with risk factors among SA in the DILWALE registry.

METHODS: Clinically indicated coronary CTAs from 341 patients in the Baylor Scott and White DILWALE registry were analyzed using Artificial intelligence enabled quantitative coronary plaque analysis (AIQCPA) to characterize age- and sex-specific plaque burden.

RESULTS: Of 341 patients, 63% (n = 215) exhibited any plaque by AIQCPA. Non-calcified plaque (NCP) was the predominant plaque subtype across all age groups, but calcified plaque volumes increased with age. The median PAV was 3.5% (IQR 0-18.5%). Age, male sex, and statin use were significant predictors of the presence of any plaque, while age and male sex predicted the presence of low attenuation plaque ≥ 10 mm3.

CONCLUSION: This study represents one of the largest CTA based cohorts evaluating plaque characteristics in SA in the United States. Our findings highlight the value of AIQCPA CTA in revealing subclinical plaque, particularly non-calcified plaque in SA. Future studies should identify optimal imaging strategies for SA along with outcome-based validation of plaque characteristics.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты